Boltz raises $110M Series A as pharma usage of its AI drug design platform grows 50x

a16z · x · 2026-11-18

AI biomolecular design startup Boltz announced a $110M Series A led by Bessemer VP, with a16z doubling down.

A landmark case of AI-for-Science commercialization in pharma.

Related event: AI drug design startup Boltz raises $110M Series A as usage surges 50x(10 posts)→

Original post →

More from Venture

Venture channel →